Dr. Michael Megaly is senior author of a JSCAI analysis of 235,340 PCIs finding no difference in 30-day mortality between CTO PCI and non-CTO PCI.

Dr. Michael Megaly delivered an invited lecture on treatment strategies for small vessel coronary artery disease at Cardiovascular Innovations (CVI 2026) in Denver, Colorado, in August 2026; the latest in a series of national faculty appearances addressing the technical and evidence-based challenges of complex coronary intervention. Small vessel coronary artery disease remains one of the most common and least resolved problems in interventional cardiology. Dr. Megaly opened b

When standard approaches fail in complex peripheral artery disease, the difference between a salvaged limb and an amputation often comes down to whether a physician has the advanced techniques and the judgment to adapt in real time Peripheral artery disease affecting the iliac arteries presents unique anatomical challenges, particularly when complete occlusion occurs alongside severe calcification in adjacent vessels. In a subset of these cases, wiring attempts create an aort

Dr. Michael Megaly of Integris Health Heart Hospital in Oklahoma City served as invited faculty at CTO Plus 2026 in New York, joining a panel on the latest CTO PCI and complex PCI research

National US data in a study led by Dr. Megaly (Oklahoma City) show STEMI (heart attacks) and mortality rising in young adults.

Dr. Megaly studies shock hospitalizations and shows Takotsubo cardiogenic shock differs from MI shock in mortality, stroke, and bleeding risk.

In December 2025, Dr. Michael Megaly, MD, MS, FACC, FSCAI, joined Integris Health Heart Hospital in Oklahoma City, Oklahoma, bringing specialized expertise in complex percutaneous coronary intervention, chronic total occlusion PCI, surgical turn-down cases, complex peripheral artery disease, and limb salvage to the region. Interventional cardiology in Oklahoma City entered a new chapter in December 2025 with the arrival of Dr. Michael Megaly at Integris Health Heart Hospital.

Dr. Michael Megaly co-authored a meta-analysis comparing IVUS- vs. OCT-guided PCI mechanical outcomes in coronary intervention imaging.

Dr. Michael Megaly's research shows CTO PCI can improve heart function beyond the LAD, expanding treatment options for patients with cardiomyopathy

Dr. Michael Megaly elected to the SCAI Finance Committee, April 2025–May 2028. Governance-level leadership in interventional cardiology.

Dr. Michael Megaly led a nationwide study showing revascularization cuts in-hospital mortality by 67% in burn patients with heart attack (myocardial infarction). Published in Burns Journal, 2025.

In October 2024, Dr. Michael Megaly traveled from the United States as invited international faculty to the Multi-level CTO Middle East conference in Cairo, Egypt, where he delivered two lectures on the planning and technical execution of chronic total occlusion percutaneous coronary intervention. Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is among the most technically demanding procedures in interventional cardiology. A CTO is a coronary artery th

Dr. Megaly presented at EuroCTO 2024 in Istanbul on CTO PCI trial vs. registry evidence gaps as invited faculty at the European CTO Society's annual meeting.

Dr. Megaly served as invited faculty at Cardiovascular Innovations (CVI) 2024 in Denver, delivering a lecture on the future of DCBs in coronary interventions.

Dr. Michael Megaly served as senior author on a landmark study published in the European Heart Journal: Acute Cardiovascular Care examining the impact of timing on mechanical circulatory support in heart attack shock. Analyzing over 160,000 patients, the research demonstrates that early device deployment — within 24 hours — is associated with lower mortality, shorter hospital stays, and fewer readmissions. The findings carry direct implications for how cardiogenic shock is ma

In March 2024, Dr. Michael Megaly was invited as faculty at Cardiovascular Research Technologies (CRT) — one of interventional cardiology's premier national meetings, to present his clinical framework for mechanical circulatory support in complex high-risk PCI. Learn what criteria drive that decision and what it means for patients in Oklahoma who've been told their case is too complex.

Dr. Michael Megaly, MD, FACC, FSCAI, appointed Clinical Assistant Professor of Cardiology at the University of Oklahoma , combining advanced interventional cardiology practice in Oklahoma